Life Healthcare Group Holdings Limited · JSE:LHC
Life Healthcare — H1 2025 Earnings Presentation
24 slides from Life Healthcare's earnings presentation, Mar 31, 2025
Slide 1: Unaudited Group interim results for the six months ended 31 March 2025
Unaudited Group interim results for the six months ended 31 March 2025 and cash dividend declaration 2025
Slide 2: Highlights
Highlights
Slide 3: Highlights
3 Highlights 2.0% 68.6% 8.1% Acute PPD1,2 growth Occupancy1 % Revenue growth 10.5% to 10.2% 9.1% 21 cps Hospitals EBITDA1 NEPS from continuing Interim dividend Interim dividend operations 1 Excludes facility sold in H1-2025 2 Paid patient days Life Healthcare 2025 Unaudited Group interim results for
Slide 4: FY2025 Progress
4 FY2025 Progress FY2025 outlook H1-2025 update Add 219 beds: 20 ICU beds added in H1-2025 • 79 beds in FY2025 62 beds expected in H2-2025 Grow • Commence build of 140-bed hospital Life Paarl Valley Hospital construction to Imaging transactions in progress commence in H2-2025 New PET-CT
Slide 5: Strategy
Strategy Peter Wharton-Hood
Slide 6: Strategy unchanged
6 Strategy unchanged GROW DRIVE OPTIMISE Grow footprint in strategic locations Drive facilities utilisation Optimise asset utilisation Greenfield expansion by targeting General practitioner (GP) channel Strategically optimise asset new builds in growth geographies Emergency unit channel util
Slide 7: Life Healthcare footprint at a glance
16 106 More than 3 000 7 7 employees specialists in our network learning centres Life Nkanyisa Acute hospitals 2 327 beds 42 facilities 8 055 acute hospital beds 7 facilities 293 theatres 4 provinces 17 cathlabs 5 vascular labs Life Health Solutions Occupational health, wellness, emergency medical E
Slide 8: Southern Africa operational review
Southern Africa operational review Peter Wharton-Hood
Slide 9: H1-2025 Southern Africa
9 H1-2025 Southern Africa Revenue by segment (R’m)1 12 000 611 Good revenue growth in hospitals and complementary 11 000 696 902 services driven by strong activity growth and benefits from 10 000 635 834 773 network arrangements 9 000 10 297 Occupancy % improvement continues 8 000 9 543 7 000 9
Slide 10: H1-2025 Acute hospitals
H1-2025 Acute hospitals 10 on a like-for-like basis Overall occupancy % Quarterly occupancy % 75 H1- 71,5 68,3 2025 68,7 68,9 70 H1- 65,1 66,2 65 63,5 2024 60,8 60 H1- 64,7 2023 55 Q1-2023 Q2-2023 Q1-2024 Q2-2024 Q1-2025 Q2-2025 • Occupancy % 68.3% • ICU occupancy % 81.8% • PPDs 2.0% YTD April 2025
Slide 11: H1-2025 Complementary services
11 H1-2025 Complementary services Mental health and rehab occupancy %1 Renal dialysis treatments Imaging volumes2 H1- H1- H1- 71,6 111 550 126 481* 23 602 2025 2025 2025 H1- H1- H1- 70,4 103 971 20 726 2024 2024 2024 H1- H1- H1- 71,7 95 795 18 213 2023 2023 2023 1 On a like-for-like basis 2 MRI/CT/P
Slide 12: Life Molecular Imaging review
Life Molecular Imaging review Pieter van der Westhuizen
Slide 13: H1-2025 Life Molecular Imaging (LMI)
13 H1-2025 Life Molecular Imaging (LMI) Discontinued operation TRANSACTION UPDATE FINANCIAL RESULTS Entered into non-binding agreement through Lantheus Meets definition of a discontinued operation Holdings Inc. in January 2025 for the sale of LMI The sale will result in an estimated net profit
Slide 14: Financial review
Financial review Pieter van der Westhuizen
Slide 15: Highlights
15 Highlights Good revenue growth from southern Expanded operational margins Africa operations on a like-for-like basis LMI transaction expected to Strong cash generated from operations close in H2-2025 17.5% ROCE1 Dividend up 10.5% 1 Calculated as operating profit/capital employed. Capital employed
Slide 16: H1-2025 | Statement of profit and loss
16 H1-2025 | Statement of profit and loss H1-2025 Pro forma H1-2025 H1-2024 Unaudited adjustment Pro forma Unaudited R’m R’m R’m R’m % Notes Revenue 12 133 12 133 11 228 8.1 1 1. Revenue growth boosted by Normalised EBITDA 1 861 1 861 1 758 5.9 2 PPD growth of 2.0%1 and strong Normalised EBITDA marg
Slide 17: H1-2025 | Southern Africa
17 H1-2025 | Southern Africa H1-2025 H1-2024 Revenue growth R’m R’m % Revenue • Strong acute hospitals and complementary growth Hospitals 10 348 9 698 6.7 • Revenue from complementary services boosted by strong Complementary services 1 174 834 40.8 performances in mental health and diagnostics and
Slide 18: H1-2025 | Cash flow from continuing operations
18 H1-2025 | Cash flow from continuing operations H1-2025 H1-2024 R’m R’m % Cash generated from operations 1 959 1 196 63.8 Strong cash generated from Transaction costs paid (2) (5) operations Net interest paid (131) (111) Tax paid (272) (204) Special dividend of R1 billion paid Maintenance cape
Slide 19: H1-2025 | Debt
19 H1-2025 | Debt Debt maturity Balance at Maturing in Maturing in Maturing in Maturing in R’m 31 Mar 2025 FY2025 FY2026 FY2027 FY2028 or later Bank debt 3 271 (521) – (1 975) (775) Lease liabilities 757 (90) (133) (91) (443) Total debt 4 028 (611) (133) (2 066) (1 218) Bank debt maturing in FY2
Slide 20: H1-2025 | Financial position
20 H1-2025 | Financial position H1-2025 FY2024 R’m R’m Non-current assets 15 894 16 809 Property, plant and equipment Strong balance sheet 11 066 10 765 Goodwill & intangibles 2 545 3 570 Capex spend (excl. acquisitions) Other 2 283 2 474 in H1-2025 of R1.1 billion Current assets (excluding cash
Slide 21: H1-2025 | Earnings per share and dividend
21 H1-2025 | Earnings per share and dividend Pro forma H1-2025 Good underlying southern Africa H1-2025 adjustment* Pro forma H1-2024 % performance resulted in a 9.1% Weighted average number of shares (’m) 1 440 1 440 1 440 1 441 (0.1) increase in NEPS Cents per share EPS/HEPS from continuing ope
Slide 22: Outlook
Life saicare
Slide 23: FY2025 Outlook statement
23 FY2025 Outlook statement 82 beds to be added in FY2025 Life Paarl Valley Hospital building to commence in H2-2025 1 new cathlab at Life Kingsbury Hospital Grow 1 new vascular lab at Life Rosepark Hospital 2 imaging transactions to be completed 2 new PET-CT sites to be opened Cyclotr
Slide 24: Questions
A oe Questions
Life Healthcare Group Holdings — H1 2025 Earnings Presentation on 6ix